Efficacy and safety of isatuximab subcutaneous plus carfilzomib and dexamethasone in patients with relapsed/refractory multiple myeloma: results of the Phase 2 study IZALCO
Year: 2025
Type: article
Language: en
Topic: Multiple Myeloma Research and Treatments
Authors and affiliations:
raw_author_name: Gurdeep Parmar
raw_affiliation_strings: Illawarra Cancer Care Centre, Wollongong Hospital, University of Wollongong, Wollongong, NSW, Australia. gurdeep.parmar@health.nsw.gov.au
raw_author_name: Marcelo Capra
raw_affiliation_strings: Centro Integrado de Hematologia e Oncologia, Hospital Mãe de Deus, Porto Alegre, Brazil
raw_author_name: Fernanda Seguro
raw_affiliation_strings: Hematologia e Hemoterapia do Hospital das Clinicas - FMUSP, São Paulo, Brazil
raw_author_name: Vania Hungria
raw_affiliation_strings: Department of Hematology and Oncology, Clínica São Germano, São Paulo, Brazil
raw_author_name: Meletios-Athanasios Dimopoulos
raw_affiliation_strings: Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece
Department of Medicine, Korea University, Seoul, South Korea
raw_author_name: Sosana Delimpasi
raw_affiliation_strings: Department of Hematology and Bone Marrow Transplantation Unit, Evangelismos General Hospital, Athens, Greece
raw_author_name: Jiří Minařík
raw_affiliation_strings: Department of Hemato-Oncology, Faculty of Medicine and Dentistry, Palacký University and University Hospital Olomouc, Olomouc, Czech Republic
raw_author_name: Ivan Špička
raw_affiliation_strings: Departments of Medicine and Hematology, First Faculty of Medicine, Charles University and General Hospital, Prague, Czech Republic
raw_author_name: Luděk Pour
raw_affiliation_strings: Department of Internal Medicine, Hematology, and Oncology, University Hospital Brno, Brno, Czech Republic
raw_author_name: Herlander Marques
raw_affiliation_strings: Department of Hematology, Hospital de Braga, Academic Clinical Center of Braga, Braga, and CINTESIS, Oporto University, Braga, Portugal
raw_author_name: Graça Esteves
raw_affiliation_strings: Hospital de Santa Maria, Centro de Investigação Clínica, Lisboa, Portugal
raw_author_name: Kazutaka Sunami
raw_affiliation_strings: Department of Hematology, NHO Okayama Medical Center, Okayama, Japan
raw_author_name: Junichiro Yuda
raw_affiliation_strings: Department of Hematology and Experimental Therapeutics, National Cancer Center Hospital East, Kashiwa, Japan
raw_author_name: Roman Hájek
raw_affiliation_strings: Department of Haemato-Oncology, University Hospital Ostrava and Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic
raw_author_name: Jana Mihályová
raw_affiliation_strings: Department of Haemato-Oncology, University Hospital Ostrava and Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic
raw_author_name: Christine Soufflet
raw_affiliation_strings: Sanofi Research & Development, Vitry-sur-Seine, France
raw_author_name: Disa Yu
raw_affiliation_strings: Sanofi Research & Development, Cambridge, MA, USA
raw_author_name: Khadija Benlhassan
raw_affiliation_strings: Excelya on Behalf of Sanofi Research & Development, Vitry-sur-Seine, France
raw_author_name: Victorine Koch
raw_affiliation_strings: Excelya on Behalf of Sanofi Research & Development, Vitry-sur-Seine, France
raw_author_name: Erin Comerford
raw_affiliation_strings: Sanofi Research & Development, Cambridge, MA, USA
raw_author_name: Paul Cordero
raw_affiliation_strings: Sanofi Research & Development, Reading, UK
raw_author_name: Florence Suzan
raw_affiliation_strings: Sanofi Research & Development, Vitry-sur-Seine, France
raw_author_name: Hang Quach
raw_affiliation_strings: Clinical Haematology Service, St Vincent's Hospital, University of Melbourne, Melbourne, VIC, Australia